Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review

BACKGROUND: Ipilimumab improves survival in metastatic melanoma patients. This population frequently develops brain metastases, which have been associated with poor survival and are often treated with radiation. Therefore, outcomes following ipilimumab and radiation are of interest, especially given...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoenfeld, Jonathan D., Mahadevan, Anand, Floyd, Scott R., Dyer, Michael A., Catalano, Paul J., Alexander, Brian M., McDermott, David F., Kaplan, Irving D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678639/
https://www.ncbi.nlm.nih.gov/pubmed/26672895
http://dx.doi.org/10.1186/s40425-015-0095-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678639/
https://www.ncbi.nlm.nih.gov/pubmed/26672895
http://dx.doi.org/10.1186/s40425-015-0095-8

Ejemplares similares